Description

Structure

Oxymetazoline g / c - 0.025 mg, 150 doses.

Auxiliary substances: benzalkonium chloride, racemic camphor, eucalyptol, levomenthol, disodium edetate dihydrate, polysorbate, propylene glycol, sodium hydrogen phosphate dihydrate, sodium dihydrogen phosphate dihydrate, hydrochloric acid conc., Purified water.

Side effects

Local reactions: sometimes a burning sensation or dryness of the nasal membranes, dryness in the mouth and throat, sneezing, an increase in the volume of secretions released from the nose.

In rare cases, after the effect of the drug has passed, a strong feeling of stuffiness" of the nose (reactive hyperemia).

Systemic reactions: increased blood pressure, headache, dizziness, palpitations, increased anxiety, nausea, insomnia.

With prolonged use of the drug (more than 7 days), reactive hyperemia of the nasal mucosa, atrophy of the nasal mucosa are possible.

Selling features

Available without a prescription

Indications

- to facilitate nasal breathing for colds and viral infections of the upper respiratory tract, sinusitis, rhinitis of any etiology.

Contraindications

- atrophic rhinitis

- children under 6 years old

- pregnancy

- lactation period

- hypersensitivity to drug components.

The drug should be used with caution in patients with diseases of the cardiovascular system (arterial hypertension, ischemic heart disease, chronic heart failure, tachycardia, arrhythmias), impaired carbohydrate metabolism (diabetes mellitus), dysfunction of the thyroid gland (hyperthyroidism), pheochromocytoma, prostatic hyperplasia with clinical symptoms, chronic renal failure, angle-closure glaucoma, with the simultaneous use of MAO inhibitors, tricyclic antidepressants.

Application during pregnancy and lactation

The drug is contraindicated during pregnancy and during breastfeeding.

Application for impaired renal function

The drug should be prescribed with caution in chronic renal failure.

Application in children

Contraindicated: children under 6 years of age.

Children aged 6 to 12 years (under the supervision of adults) - 1 injection into each nasal passage 2 times / day.

Dosage

Adults and children over 12 years old are prescribed 2-3 injections into each nasal passage 2 times / day, children aged 6 to 12 years (under the supervision of adults) - 1 injection into each nasal passage 2 times / day.

Do not use the drug more than 2 times / day.

It is not recommended to use the drug for more than 3 days.

With frequent or prolonged use of the drug, the feeling of difficulty in nasal breathing may reappear or worsen.

If these symptoms appear, you should stop treatment and consult a doctor.

When injecting, do not tilt your head back and do not spray while lying down.

Name ENG

NAZOL ADVANCE

Clinical and pharmacological group

A vasoconstrictor drug for local use in ENT practice

ATX code

Oxymetazoline

Dosage

0.025mg / dose x 10ml

Structure

Oxymetazoline g / c - 0.025 mg, 150 doses.

Auxiliary substances: benzalkonium chloride, racemic camphor, eucalyptol, levomenthol, disodium edetate dihydrate, polysorbate, propylene glycol, sodium hydrogen phosphate dihydrate, sodium dihydrogen phosphate dihydrate, hydrochloric acid conc., Purified water.

Indications

To facilitate nasal breathing in case of colds and viral infections of the upper respiratory tract, sinusitis and rhinitis of any etiology.

INN / Active ingredient

oxymetazoline hydrochloride

Contraindications

Hypersensitivity to the drug or its components, atrophic rhinitis,, angle-closure glaucoma, severe atherosclerosis,, conditions after transsphenoidal hypophysectomy, the simultaneous use of monoamine oxidase inhibitors (including a period of 14 days after their withdrawal), children under 6 years of age, pregnancy , lactation period.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Specifications